Chamber assisted inhalant treatment (CAIR).

Area of Science:

• Pediatric Pulmonology
• Respiratory Medicine
• Medical Device Technology

Background:

• Severe asthma in children poses significant challenges to patient health and healthcare resource utilization.
• Hand-held inhaler medications are standard but adherence and efficacy can be issues in pediatric populations.
• Existing delivery devices may not be optimal for infants and young children.

Purpose of the Study:

• To evaluate the efficacy of a novel inhalation therapy device, the CAIR chamber, in managing severe asthma in pediatric patients.
• To assess the impact of the CAIR chamber on medication dependence and healthcare utilization.
• To compare patient outcomes before and after the introduction of the CAIR chamber therapy.

Main Methods:

• A trial was conducted with 17 children diagnosed with severe asthma.
• Patients served as their own controls, comparing outcomes pre- and post-CAIR chamber use.
• Parameters assessed included medication dependence and utilization of hospital, emergency room, and office facilities.

Main Results:

• An approximate 50% improvement was observed across all studied parameters.
• A notable 94% reduction in hospitalizations was recorded.
• The study involved a cumulative observation period of 104 months.

Conclusions:

• The CAIR chamber inhalation therapy device demonstrates significant clinical benefits for severe pediatric asthma.
• This device effectively reduces the need for hospitalizations and other healthcare resources in children with severe asthma.
• The findings support the use of the CAIR chamber as a valuable tool in managing pediatric asthma.